Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

NCT00178854 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT00178854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00178854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2004
Completion date
March 31, 2006
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression